Target intelligence / Profile preview

Novel transcript, antisense to KCNA3

Molecular classification
Other, non-coding RNA, antisense RNA
01

Overview

The "novel transcript, antisense to KCNA3" (ENSG00000300042) is a non-coding RNA transcript identified in genome annotations as being transcribed from the DNA strand opposite to the KCNA3 gene, whose product is the potassium voltage-gated channel subfamily A member 3. As an antisense RNA, its main characteristic is its genomic position rather than any established biological or pharmacological function. There is no evidence that this transcript produces a functional protein, or that it has been implicated as a direct therapeutic target, disease biomarker, or in any clinical context[6]. Summary of issues: This entry does not meet the criteria for a canonical therapeutic target, and information on biological relevance, function, or druggability is lacking. If your interest is KCNA3, refer to "Potassium voltage-gated channel subfamily A member 3" (KCNA3), which is a well-characterized ion channel with significant biological and clinical relevance[1][2][3].

Other names
ENSG00000300042

Beyond the preview

Go deeper on Novel transcript, antisense to KCNA3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to KCNA3.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call